Abbott Laboratories Net Profit Margin 2010-2025 | ABT

Current and historical net profit margin for Abbott Laboratories (ABT) from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Abbott Laboratories net profit margin for the three months ending March 31, 2025 was .
Abbott Laboratories Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-03-31 $42.34B $13.50B 31.89%
2024-12-31 $41.95B $13.40B 31.95%
2024-09-30 $41.22B $5.77B 13.99%
2024-06-30 $40.73B $5.56B 13.65%
2024-03-31 $40.33B $5.63B 13.96%
2023-12-31 $40.11B $5.72B 14.27%
2023-09-30 $39.96B $5.16B 12.92%
2023-06-30 $40.23B $5.16B 12.83%
2023-03-31 $41.51B $5.80B 13.98%
2022-12-31 $43.65B $6.93B 15.88%
2022-09-30 $45.03B $7.89B 17.52%
2022-06-30 $45.55B $8.55B 18.78%
2022-03-31 $44.51B $7.73B 17.35%
2021-12-31 $43.08B $7.07B 16.42%
2021-09-30 $42.31B $7.24B 17.12%
2021-06-30 $40.23B $6.38B 15.85%
2021-03-31 $37.34B $5.72B 15.33%
2020-12-31 $34.61B $4.50B 12.99%
2020-09-30 $32.22B $3.38B 10.50%
2020-06-30 $31.44B $3.11B 9.89%
2020-03-31 $32.10B $3.58B 11.15%
2019-12-31 $31.90B $3.69B 11.56%
2019-09-30 $31.36B $3.29B 10.50%
2019-06-30 $30.94B $2.90B 9.36%
2019-03-31 $30.72B $2.62B 8.53%
2018-12-31 $30.58B $2.37B 7.74%
2018-09-30 $30.40B $0.89B 2.91%
2018-06-30 $29.58B $0.93B 3.13%
2018-03-31 $28.45B $0.48B 1.67%
2017-12-31 $27.39B $0.48B 1.74%
2017-09-30 $25.13B $2.10B 8.37%
2017-06-30 $23.61B $1.17B 4.96%
2017-03-31 $22.30B $1.50B 6.74%
2016-12-31 $20.85B $1.40B 6.71%
2016-09-30 $20.71B $1.37B 6.61%
2016-06-30 $20.56B $2.28B 11.08%
2016-03-31 $20.39B $2.45B 12.00%
2015-12-31 $20.41B $4.42B 21.68%
2015-09-30 $20.57B $4.56B 22.17%
2015-06-30 $20.50B $4.52B 22.04%
2015-03-31 $20.39B $4.20B 20.60%
2014-12-31 $20.25B $2.28B 11.28%
2014-09-30 $18.90B $1.97B 10.42%
2014-06-30 $18.65B $2.40B 12.86%
2014-03-31 $19.03B $2.41B 12.65%
2013-12-31 $19.66B $2.58B 13.10%
2013-09-30 $18.84B $3.04B 16.13%
2013-06-30 $19.28B $4.02B 20.83%
2013-03-31 $19.14B $5.27B 27.50%
2012-12-31 $19.05B $5.96B 31.30%
2012-09-30 $26.24B $6.53B 24.88%
2012-06-30 $30.79B $4.89B 15.88%
2012-03-31 $35.09B $5.11B 14.55%
2011-12-31 $38.85B $4.73B 12.17%
2011-09-30 $38.44B $4.55B 11.84%
2011-06-30 $37.30B $5.14B 13.78%
2011-03-31 $36.51B $4.49B 12.29%
2010-12-31 $35.17B $4.63B 13.16%
2010-09-30 $33.99B $4.73B 13.90%
2010-06-30 $33.08B $5.31B 16.07%
2010-03-31 $31.74B $5.31B 16.73%
2009-12-31 $30.76B $5.75B 18.68%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $229.711B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $154.351B 38.64
Stryker (SYK) United States $149.416B 31.24
EssilorLuxottica (ESLOY) France $132.057B 0.00
Medtronic (MDT) Ireland $115.083B 16.32
Lonza Group Ag (LZAGY) Switzerland $49.624B 0.00
Haleon (HLN) United Kingdom $44.474B 25.39
ResMed (RMD) United States $37.259B 27.99
Agilent Technologies (A) United States $34.110B 22.24
GE HealthCare Technologies (GEHC) United States $34.090B 16.18
Terumo (TRUMY) Japan $24.459B 31.77
Koninklijke Philips (PHG) Netherlands $23.149B 16.24
Insulet (PODD) United States $20.550B 80.67
Zimmer Biomet Holdings (ZBH) United States $18.570B 11.93
Baxter (BAX) United States $14.641B 10.93
Smith & Nephew SNATS (SNN) United Kingdom $13.157B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.825B 23.75
Lantheus Holdings (LNTH) United States $5.747B 14.50
Prestige Consumer Healthcare (PBH) United States $3.776B 16.87
Perrigo (PRGO) Ireland $3.768B 9.55
Haemonetics (HAE) United States $3.683B 16.77
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.395B 28.21
ICU Medical (ICUI) United States $3.220B 23.75
QuidelOrtho (QDEL) United States $1.952B 13.42
LeMaitre Vascular (LMAT) United States $1.900B 42.47
AtriCure (ATRC) United States $1.550B 0.00
Acuren (TIC) United States $1.455B 0.00
Green Thumb Industries (GTBIF) United States $1.374B 30.91
Phibro Animal Health (PAHC) United States $1.278B 16.34
AdaptHealth (AHCO) United States $1.237B 12.56
Neogen (NEOG) United States $1.133B 14.50
BioLife Solutions (BLFS) United States $1.053B 0.00
InMode (INMD) Israel $0.932B 9.39
Kestra Medical Technologies (KMTS) United States $0.792B 0.00
Curaleaf Holdings (CURLF) Canada $0.749B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.680B 0.00
Tilray Brands (TLRY) Canada $0.661B 0.00
Owens & Minor (OMI) United States $0.616B 5.11
Evolus (EOLS) United States $0.613B 0.00
CeriBell (CBLL) United States $0.592B 0.00
Valneva SE (VALN) France $0.517B 0.00
Surmodics (SRDX) United States $0.449B 0.00
SNDL (SNDL) Canada $0.415B 0.00
Capricor Therapeutics (CAPR) United States $0.337B 0.00
VAREX IMAGING (VREX) United States $0.327B 12.02
Sanuwave Health (SNWV) United States $0.310B 0.00
Cresco Labs (CRLBF) United States $0.306B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Quanterix (QTRX) United States $0.302B 0.00
Cerus (CERS) United States $0.277B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.40
Aurora Cannabis (ACB) Canada $0.257B 76.33
Sanara MedTech (SMTI) United States $0.257B 0.00
ZimVie (ZIMV) United States $0.249B 11.30
Brainsway (BWAY) Israel $0.231B 61.17
Omeros (OMER) United States $0.230B 0.00
OraSure Technologies (OSUR) United States $0.230B 0.00
Verano Holdings (VRNOF) United States $0.226B 0.00
Biote (BTMD) United States $0.221B 6.22
Canopy Growth (CGC) Canada $0.215B 0.00
Organigram Global (OGI) Canada $0.198B 0.00
High Tide (HITI) Canada $0.195B 0.00
TriSalus Life Sciences (TLSI) United States $0.188B 0.00
Utah Medical Products (UTMD) United States $0.184B 15.00
Vireo Growth (VREOF) United States $0.162B 0.00
Exagen (XGN) United States $0.151B 0.00
FitLife Brands (FTLF) United States $0.123B 15.13
TerrAscend (TSNDF) Canada $0.115B 0.00
Fonar (FONR) United States $0.101B 13.05
MacroGenics (MGNX) United States $0.100B 0.00
Jin Medical (ZJYL) China $0.094B 0.00
Jushi Holdings (JUSHF) United States $0.092B 0.00
Veru (VERU) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.083B 0.00
Apyx Medical (APYX) United States $0.074B 0.00
InterCure (INCR) Israel $0.071B 0.00
Agape ATP (ATPC) $0.069B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Nephros (NEPH) United States $0.040B 54.00
Safety Shot (SHOT) United States $0.040B 0.00
Modular Medical (MODD) United States $0.039B 0.00
Rockwell Medical (RMTI) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 12.87
Allurion Technologies (ALUR) United States $0.021B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
IM Cannabis (IMCC) Canada $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00